HD-B001A
Stage unconfirmedBiliary-tract cancer candidate for which Handok holds Korean commercial rights; its partner is reporting late-stage trial results.
A pharmaceutical company selling prescription and over-the-counter medicines, commercialising in-licensed new drugs such as a biliary-tract cancer candidate and an insomnia digital therapeutic.
Biliary-tract cancer candidate for which Handok holds Korean commercial rights; its partner is reporting late-stage trial results.
A launched digital therapeutic for insomnia.
Official role guide
Observed 2026-11-15
Information from a role guide does not establish a current vacancy.
A brief based on selected official material, not an exhaustive product or vacancy list.